Tango Therapeutics CFO sells $126,530 in TNGX stock

robot
Abstract generation in progress

Tango Therapeutics CFO Daniella Beckman sold 10,317 shares of TNGX common stock for approximately $126,530. These sales were primarily to cover tax obligations related to restricted stock unit vesting. Despite the sales, Beckman also acquired significant restricted stock units and stock options, increasing her total direct ownership to 184,297 shares.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin